| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |